Sinemet CR 100/25 and Trastuzumab and Hyaluronidase
Determining the interaction of Sinemet CR 100/25 and Trastuzumab and Hyaluronidase and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Hyaluronidase and trastuzumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sinemet CR 100/25-Trastuzumab Injection (Intravenous)
- Sinemet CR 100/25-Trastuzumab Intravenous
- Sinemet CR 100/25-Trastuzumab-anns
- Sinemet CR 100/25-Trastuzumab-dkst
- Sinemet CR 100/25-Trastuzumab-dkst Intravenous
- Sinemet CR 100/25-Trasylol
- Trastuzumab and Hyaluronidase-Sinemet CR 200/50
- Trastuzumab and Hyaluronidase-Sinequan
- Trastuzumab and Hyaluronidase-Sinequan (Doxepin Capsules)
- Trastuzumab and Hyaluronidase-Sinequan (Doxepin Oral Concentrate)
- Trastuzumab and Hyaluronidase-Sinex Long-Acting
- Trastuzumab and Hyaluronidase-Sinex Nasal Spray